Sort
82,697 grants matching “vaccine development”
Innate Immunity
$803,784Bali Pulendran · Emory University · U19 · FY2010 · AI
Impairment of anti-Plasmodium T cell memory by type I Interferon Signaling
$803,778Nana Kwaku Minkah · Seattle Children'S Hospital · R01 · FY2024 · AI
Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical Trials
$803,751Marya Gwadz · National Development And Research Institutes, Inc. · R01 · FY2008 · AI
Identification of the Initial Targets of Transmission
$803,750Thomas Hope · Northwestern University At Chicago · R01 · FY2011 · AI
Molecular Analysis of Host Immune Response in Leprosy
$803,706Robert L Modlin · University Of California Los Angeles · R01 · FY2024 · AI
Mechanisms of atherosclerotic cardiovascular complications in COVID19
$803,677Chiara Giannarelli · New York University School Of Medicine · R01 · FY2022 · HL
HPV Vaccine Trial
$803,654Allan Hildesheim · Division Of Cancer Epidemiology And Genetics · ZIA · FY2020 · CA
Molecular Genetic Analysis of Mycobacterium Tuberculosis
$803,583William Robert Jacobs · Albert Einstein College Of Medicine · R37 · FY2023 · AI
Human Immunology Center at the University of Rochester
$803,516Tim Mosmann · University Of Rochester · R24 · FY2007 · AI
Lipid nanoparticle adjuvants for mRNA vaccines: composition-function relation and mechanism of action
$803,514Norbert Pardi · University Of Pennsylvania · R01 · FY2025 · AI
Pediatric HIV/AIDS Cohort Study (PHACS) 2020
$803,491Paige L Williams · Harvard School Of Public Health · P01 · FY2021 · HD
Reverse Vaccinology in SHIV Infected Macaques as a Molecular Guide for HIV-1 Vaccine Design
$803,474George M Shaw · University Of Pennsylvania · R01 · FY2021 · AI
Genetic Epidemiology of Chagas Disease Progression
$803,419Sarah A. Williams-Blangero · Texas Biomedical Research Institute · R01 · FY2009 · HL
Dys/Regulation of the Immune System in Autoimmunity
$803,353Yale University · P01 · FY2002 · AI
Prophylactic oral vaccination for SIV and SHIV infections and AIDS prevention
$803,313Anna Aldovini · Boston Children'S Hospital · R01 · FY2017 · DE
An Expanded Multivalent Vaccine to Prevent MDR Shigella and ETEC Disease
$803,296Eileen M. Barry · University Of Maryland Baltimore · U19 · FY2021 · AI
HIV-1 Q23.17 Env: Engineering a novel immunogen to elicit broadly neutralizing antibodies
$803,267George M Shaw · University Of Pennsylvania · R01 · FY2021 · AI
NIAID Preclinical Development Support
$803,174Fred Mack · Advanced Bioscience Laboratories, Inc. · N01 · FY2019 · AI
Clinical Interventional Studies of HIV Reservoirs
$803,104Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV
$803,093Roger Keith Reeves · Duke University · R01 · FY2025 · AI
Novel Methods to Inform HIV/TB Clinical Trial Development
$803,055Krishna P Reddy · Massachusetts General Hospital · R01 · FY2023 · AI
Exploiting the antigenic conservation of the Env trimer apex across primate lentiviral lineages for AIDS vaccine design
$802,998Beatrice H Hahn · University Of Pennsylvania · R01 · FY2021 · AI
IMPDH inhibitors for the treatment of Cryptosporidium infections
$802,966Gregory D Cuny · University Of Houston · R01 · FY2016 · AI
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
$802,815Charles Bix Shoemaker · Tufts University Boston · R01 · FY2024 · AI
Optimization of Small-Molecule Inhibitors of Shiga and Ricin Toxins
$802,815Yuan-Ping Pang · Mayo Clinic Rochester · U01 · FY2009 · AI